日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/01/30 | 5,252 | 5,316 | 5,224 | 5,234 | -7 | -0.1% | 354,800 |
| 2024/01/29 | 5,287 | 5,330 | 5,212 | 5,241 | -10 | -0.2% | 244,900 |
| 2024/01/26 | 5,249 | 5,298 | 5,230 | 5,251 | -17 | -0.3% | 280,900 |
| 2024/01/25 | 5,283 | 5,321 | 5,193 | 5,268 | -30 | -0.6% | 203,400 |
| 2024/01/24 | 5,216 | 5,327 | 5,207 | 5,298 | +118 | +2.3% | 358,900 |
| 2024/01/23 | 5,192 | 5,255 | 5,165 | 5,180 | +60 | +1.2% | 181,100 |
| 2024/01/22 | 5,126 | 5,145 | 5,093 | 5,120 | +19 | +0.4% | 138,900 |
| 2024/01/19 | 5,112 | 5,131 | 5,071 | 5,101 | -9 | -0.2% | 273,200 |
| 2024/01/18 | 5,087 | 5,130 | 5,084 | 5,110 | +1 | ±0% | 209,200 |
| 2024/01/17 | 5,154 | 5,177 | 5,088 | 5,109 | -48 | -0.9% | 288,800 |
| 2024/01/16 | 5,185 | 5,217 | 5,145 | 5,157 | -45 | -0.9% | 190,300 |
| 2024/01/15 | 5,286 | 5,286 | 5,177 | 5,202 | -56 | -1.1% | 216,300 |
| 2024/01/12 | 5,253 | 5,278 | 5,197 | 5,258 | +69 | +1.3% | 377,900 |
| 2024/01/11 | 5,290 | 5,290 | 5,175 | 5,189 | -51 | -1% | 375,900 |
| 2024/01/10 | 5,225 | 5,274 | 5,204 | 5,240 | -8 | -0.2% | 308,900 |
| 2024/01/09 | 5,246 | 5,269 | 5,189 | 5,248 | +56 | +1.1% | 198,600 |
| 2024/01/05 | 5,255 | 5,256 | 5,162 | 5,192 | -62 | -1.2% | 244,000 |
| 2024/01/04 | 5,066 | 5,258 | 5,031 | 5,254 | +258 | +5.2% | 435,600 |
| 2023/12/29 | 4,981 | 5,006 | 4,962 | 4,996 | +1 | ±0% | 159,700 |
| 2023/12/28 | 5,000 | 5,019 | 4,936 | 4,995 | +44 | +0.9% | 147,500 |
| 2023/12/27 | 4,875 | 4,959 | 4,875 | 4,951 | +76 | +1.6% | 181,300 |
| 2023/12/26 | 4,890 | 4,908 | 4,839 | 4,875 | -21 | -0.4% | 195,300 |
| 2023/12/25 | 4,930 | 4,941 | 4,883 | 4,896 | -10 | -0.2% | 115,900 |
| 2023/12/22 | 4,899 | 4,959 | 4,892 | 4,906 | +60 | +1.2% | 176,000 |
| 2023/12/21 | 4,899 | 4,910 | 4,837 | 4,846 | -105 | -2.1% | 202,600 |
| 2023/12/20 | 4,981 | 5,028 | 4,950 | 4,951 | -20 | -0.4% | 225,500 |
| 2023/12/19 | 4,937 | 4,976 | 4,888 | 4,971 | +46 | +0.9% | 289,200 |
| 2023/12/18 | 4,798 | 4,933 | 4,763 | 4,925 | +57 | +1.2% | 383,900 |
| 2023/12/15 | 4,975 | 5,018 | 4,825 | 4,868 | -166 | -3.3% | 724,000 |
| 2023/12/14 | 5,098 | 5,118 | 4,963 | 5,034 | -33 | -0.7% | 352,000 |
| 2023/12/13 | 5,058 | 5,090 | 5,001 | 5,067 | -29 | -0.6% | 452,900 |
| 2023/12/12 | 5,120 | 5,186 | 5,085 | 5,096 | +38 | +0.8% | 365,500 |
| 2023/12/11 | 5,008 | 5,075 | 4,995 | 5,058 | +48 | +1% | 441,700 |
| 2023/12/08 | 5,080 | 5,089 | 4,992 | 5,010 | -106 | -2.1% | 484,700 |
| 2023/12/07 | 5,222 | 5,222 | 5,108 | 5,116 | -124 | -2.4% | 349,700 |
| 2023/12/06 | 5,241 | 5,245 | 5,164 | 5,240 | +20 | +0.4% | 345,000 |
| 2023/12/05 | 5,239 | 5,270 | 5,203 | 5,220 | -30 | -0.6% | 314,400 |
| 2023/12/04 | 5,250 | 5,268 | 5,204 | 5,250 | -58 | -1.1% | 215,300 |
| 2023/12/01 | 5,390 | 5,394 | 5,285 | 5,308 | -23 | -0.4% | 212,400 |
| 2023/11/30 | 5,250 | 5,338 | 5,238 | 5,331 | +54 | +1% | 408,200 |
| 2023/11/29 | 5,313 | 5,345 | 5,255 | 5,277 | -64 | -1.2% | 292,000 |
| 2023/11/28 | 5,325 | 5,377 | 5,277 | 5,341 | +9 | +0.2% | 424,200 |
| 2023/11/27 | 5,390 | 5,410 | 5,296 | 5,332 | -79 | -1.5% | 394,200 |
| 2023/11/24 | 5,490 | 5,490 | 5,396 | 5,411 | -45 | -0.8% | 254,500 |
| 2023/11/22 | 5,443 | 5,482 | 5,412 | 5,456 | +12 | +0.2% | 280,900 |
| 2023/11/21 | 5,398 | 5,449 | 5,278 | 5,444 | +77 | +1.4% | 378,100 |
| 2023/11/20 | 5,370 | 5,404 | 5,327 | 5,367 | -42 | -0.8% | 463,600 |
| 2023/11/17 | 5,224 | 5,409 | 5,195 | 5,409 | +198 | +3.8% | 677,700 |
| 2023/11/16 | 5,500 | 5,508 | 5,209 | 5,211 | -332 | -6% | 899,700 |
| 2023/11/15 | 5,550 | 5,567 | 5,405 | 5,543 | +63 | +1.1% | 634,000 |
201～
250
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 423,000円 | +5.9% | 0.0% | 2.93% | 9.50倍 | 1.21倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 428,300円 | +7.3% | -3.8% | 2.10% | 19.89倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ペプチド | 270,100円 | +56.7% | +357.2% | 0.00% | 25.00倍 | 5.95倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 196,300円 | +4.0% | +25.4% | 2.70% | 9.07倍 | 1.19倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 住友ファーマ | 60,900円 | +7.5% | - | 0.00% | - | 2.12倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム
